TEM - Transaction in Own Shares

TEM bought 42,769 shares at 299.29 pence each for cancellation on 4 Nov 2026. Its share capital now totals 900,202,856 shares, with 60,000,000 held in treasury. Treasury shares will only be reissued above the prevailing NAV per share.

Original reporting
Published Nov 4, 2026, 11:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$TEM
Bullish
medium confidence
Mentioned
$TEM
Relevance
6/10
AlphAI data visualization · based on sharechat.co.nz
Decision brief

The 30-second read

$TEMBullishLow
01

Why it matters

A small-scale share repurchase that slightly reduces float and may provide a modest price boost.

02

Market read

Limited relevance; primarily of interest to current shareholders and short‑term traders.

03

What to watch

Potential future buyback plans or changes in treasury share policy could affect valuation.

Relevance 6/10Novelty 5/10Timing: same-day announcement

Background

The announcement was made via an RNS filing on the London Stock Exchange, indicating a routine corporate action.

Company-level read

Ticker impact

$TEMBullishMedium confidence
Context

The company disclosed a share buyback of 42,769 ordinary shares at 299.29 pence each, reducing outstanding shares.

Expected impact

likely modest upward pressure as the market prices the buyback

Evidence & confidence

Buybacks typically lift share price, but the amount is small relative to total shares outstanding.

Market effects

Minimal impact on the broader sector; only relevant to investors in the specific company.

Limited to the UK market where the shares are listed.

Low

Counterpoint

The buyback size is negligible and may not move the stock; investors could focus on larger catalysts.

Key entities

  • TEM

    Issuer of the shares being repurchased.

Related articles

Med

Tempus CEO Eric Lefkofsky: A Blood Draw Can Catch Returning Cancer 6 to 12 Months Before a Scan

Tempus CEO Eric Lefkofsky reported a record quarter with 23% revenue growth, driven by 32% growth in cancer testing and 33% in data & AI applications. The company signed three $100M+ deals, including with Merck and Bristol Myers Squibb. Tempus claims its blood tests can detect cancer recurrence 6-12 months earlier than scans, leveraging its 600-petabyte data trove and 8,000 hospital integrations. The company is acquiring Personalis to expand into recurrence detection.

$TEMMedAI 8/10

BTIG raises Tempus AI stock price target to $100 on data deals

BTIG raised its price target for Tempus AI (NASDAQ:TEM) to $100, citing strong quarterly results, raised guidance, and significant data deals, including a $200M agreement with Bristol Myers Squibb. The company reported 50% revenue growth and positive adjusted EBITDA. Other analysts also raised price targets, noting strong performance in data and diagnostics segments.

$TEMLow

Jefferies upgrades Tempus AI stock rating to hold, raises price target to $70

Jefferies upgraded Tempus AI (TEM) from Underperform to Hold, raising its price target to $70. The stock, currently at $78.48, has gained 43% in six months. The firm cited strong revenue growth, strategic collaborations, and FDA approval plans. Tempus reported Q3 2026 earnings of $0.07 per share, beating estimates, with revenue up 23% to $411.5 million. Needham raised its price target to $89, citing data business growth.

$TEMMed

Tempus AI Inc (TEM) Q3 2026 Earnings Call Highlights: Revenue Jumps 23%

Tempus AI Inc (TEM) reported Q3 2026 revenue of $411M, up 23%. CEO Lefkofsky expects sustainable 25%+ growth, with oncology and data segments driving performance. The company anticipates mid-2027 breakeven for Personalis' MRD test and predicts strong market share in MRD. Tempus also highlighted long-term data business commitments and AI-driven customer stickiness.